Grab This Bargain Even Cheaper Than CEO Fambrough Did
September 08, 2020 at 11:05 AM EDT
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on September 1, Dicerna Pharmaceuticals Inc's CEO, Douglas Fambrough, invested $180,597.00 into 10,000 shares of DRNA, for a cost per share of $18.06..